Cognigenics
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
770 SE Indian St PMB 105, Stuart, Florid...Phone Number
(772) 324-8800Website
www.cognigenics.ioRevenue
<$5 MillionIndustry
About Cognigenics
Cognigenics is a leader in RNA-based therapeutics designed to transform the treatment of mental health and neurocognitive disorders. Utilizing innovative genetic neuroengineering techniques, the company targets neural networks involved in conditions such as anxiety, depression, and cognitive decline. Their patent-pending technology aims to enhance cognitive health and improve functions like focus and mental clarity while maintaining a favorable safety profile. Cognigenics' approaches promise superior efficacy compared to traditional treatments, making it a potential game-changer in mental health care.Explore more
Cognigenics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cognigenics
Compare insights from companies similar to Cognigenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cognigenics Tech Stack
A closer look at the technologies used by Cognigenics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cognigenics
Sign Up For FreeTo access detailed company insights
Cognigenics is a leader in RNA-based therapeutics designed to transform the treatment of mental health and neurocognitive disorders. Utilizing innovative genetic neuroengineering techniques, the company targets neural networks involved in conditions such as anxiety, depression, and cognitive decline. Their patent-pending technology aims to enhance... Read More
